ArticleProceedings of the National Academy of Sciences of the United States of America2022

Inhibition of RAS-driven signaling and tumorigenesis with a pan-RAS monobody targeting the Switch I/II pocket.

Lauren Wallon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.